Gabapentin and lamotrigine in bipolar disorder

American Journal of Health-System Pharmacy

Volumn 56, Issue 19, 1999, Pages 1939-1944

  Botts, Sheila R ^a   Raskind, Jackie ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

Antimanic agents; Bipolar disorder; Clinical studies; Gabapentin; Lamotrigine

Indexed keywords

GABAPENTIN; LAMOTRIGINE;

ANTICONVULSANT ACTIVITY; CLINICAL TRIAL; DRUG EFFICACY; DRUG ERUPTION; DRUG RESISTANCE; HUMAN; HYPOMANIA; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; REVIEW;

EID: 0033214794     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/56.19.1939     Document Type: Review

References (36)

1. Dubovsky SL, Buzan RD. Novel alternatives and supplements to lithium and anticonvulsants for bipolar affective disorder. J Clin Psychiatry. 1997; 58:224-42.
2. Post RM, Ketter TA, Denicoff K et al. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology. 1996; 128: 115-29.
3. Kusumaker V, Yatham L, Parikh S. Bipolar disorder: a summary of clinical issues and treatment options, www.mentalhealth. com/rx2/bp-can1.html (accessed 1998 Aug 18).
4. Bowden CL. Role of newer medications for bipolar disorder. J Clin Psychopharmacol. 1996; 16(suppl 1):48S-54S.
5. Calabrese JR, Fatemi SH, Kujawa M et al. Predictors of response to mood stabilizers. J Clin Psychopharmacol. 1996; 16 (suppl 1):24S-30S.
6. Fankhauser MP, Benefield WH Jr. Bipolar disorders. In: Dipiro JT, Talbert RL, Yee GC et al., eds. Pharmacotherapy: a pathophysiologic approach. 3rd ed. Stamford, CT: Appleton & Lange; 1993:1419-42.
7. Nathan KI, Musselman DL, Schatzberg AF et al. Biology of mood disorders. In: Schatzberg AF, Nemeroff CB, eds. Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press; 1995:439-77.
8. Goodwin FK, Jamison KR. Biochemical and pharmacological studies. In: Goodwin FK, Jamison KR, eds. Manic-depressive illness. New York: Oxford Univ. Press; 1990:416-502.
9. Post RM, Weiss S, Chuang DM. Mechanisms of action of anticonvulsants in affective disorders: comparisons with lithium. J Clin Psychopharmacol. 1992; 12(suppl 1):23S-32S.
10. Weiss SRB, Post RM. Kindling: separate vs. shared mechanisms in affective disorders and epilepsy. Neuropsychobiology. 1998; 38:167-80.
11. Meldrum BD. Update on the mechanism of action of antiepileptic drugs. Epilepsia. 1996; 37(suppl 6):S4-11.
12. Semanchuk MR, Labiner DM. Gabapentin and lamotrigine: prescribing guidelines for psychiatry. J Pract Psychiatry Behav Health. 1997; 3:334-42.
13. Ryback R, Ryback L. Gabapentin for behavioral dyscontrol. Am J Psychiatry. 1995; 152:1399. Letter.
14. Stanton SP, Keck PE, McElroy SL. Treatment of acute mania with gabapentin. Am J Psychiatry. 1997; 154:287. Letter.
15. Schaffer CB, Schaffer LC. Gabapentin in the treatment of bipolar disorder. Am J Psychiatry. 1997; 154:291-2. Letter.
16. McElroy SL, Soutullo CA, Keck PE et al. A pilot trial of adjunctive gabapentin therapy in the treatment of bipolar disorder. Ann Clin Psychiatry. 1997; 9:99-103.
17. Ryback RS, Brodsky L, Munasifi F. Gabapentin in bipolar disorder. J Neuropsychiatry Clin Neurosci. 1997; 2:301. Letter.
18. Young LT, Robb JC, Patelis-Siotis I et al. Acute treatment of bipolar depression with gabapentin. Biol Psychiatry. 1997; 42: 851-3.
19. Bennett J, Goldman WT, Suppes T. Gabapentin for the treatment of bipolar and schizoaffective disorder. J Clin Psychopharmacol. 1997; 17:141-2. Letter.
20. Ghaemi SN, Katzow JJ, Desai SP et al. Gabapentin treatment of mood disorders: a preliminary study. J Clin Psychiatry. 1998; 59:426-9.
21. Knoll J, Stegman K, Suppes T. Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. J Affect Disord. 1998; 49:229-33.
22. Frye MA, Ketter TA, Kimbrell TA et al. Gabapentin and lamotrigine monotherapy in mood disorder. Paper presented at 150th Annual Meeting of the American Psychiatric Association. San Diego, CA; 1997 May 17-22.
23. Post RM, Denicoff KD, Frye MA et al. A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century. Neuropsychobiology. 1998; 38:152-66.
24. Shorte C, Cooke L. Hypomania induced by gabapentin. Br J Psychiatry. 1995; 166:679-80. Letter.
25. Smith D, Baker G, Davies G et al. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia. 1993; 34: 312-22.
26. Walden J, Hesslinger D, Van Caulker D et al. Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder. Pharmacopsychiatry. 1996; 29:193-5.
27. Calabrese JR, Fatemi SH, Woyshville MJ et al. Antidepressant effects of lamotrigine in rapid cycling bipolar disorder. Am J Psychiatry. 1996; 153:1236. Letter.
28. Calabrese JR, Bowden CL, Rhodes LJ et al. Lamotrigine in treatment-refractory bipolar disorder, Paper presented at the Annual Meeting of the American Psychiatric Association. New York, NY; 1996 May 4-9.
29. Kusumakar V, Yatham LN. An open study of lamotrigine in refractory bipolar depression. Psychiatry Res. 1997; 72:145-8.
30. Fogelson DL, Sternbach H. Lamotrigine treatment of refractory bipolar disorder. J Clin Psychiatry. 1997; 58:271-3. Letter.
31. Sporn J, Sachs G. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol. 1997; 17:185-9.
32. Kusumakar V, Yatham LN. Lamotrigine treatment of rapid cycling bipolar disorder. Am J Psychiatry. 1997; 154:1171-2. Letter.
33. Fatemi SH, Rapport DJ, Calabrese JR et al. Lamotrigine in rapid cycling bipolar disorder. J Clin Psychiatry. 1997; 58:522-7.
34. Labbate LA, Rubey RN. Lamotrigine for treatment-refractory bipolar disorder. Am J Psychiatry. 1997; 154:1317. Letter.
35. Kotler M, Matar MA. Lamotrigine in the treatment of resistant bipolar disorder. Clin Neuropharmacol. 1998; 21:65-7.
36. Lamictal package insert. Research Triangle Park, NC: Catalytica Pharmaceuticals; 1997 Oct.